Pom sued the FTC
seeking a declaratory judgment that the FTC's allegedly new rule governing
disease claims in food advertising (as set forth in its consent judgments with
Iovate and Nestle) exceeded the FTC's statutory authority, violated POM's
rights under the First and Fifth Amendments of the U.S. Constitution, violated
the rulemaking procedures of the FTC and the Administrative Procedure Act
(“APA”), and was arbitrary and capricious.
To no one’s surprise, the court declined to exercise its jurisdiction
and dismissed the case.
The FTC filed an
administrative complaint against POM shortly after POM filed this case, and won
it (though not on its most aggressive theory), a decision that is under
appeal and under
PR assault by POM. In that
proceeding, POM asserted the same statutory and constitutional defenses. Nonetheless, POM argued that its complaint in
the district court was not attempting to adjudicate anticipatory defenses, but
only whether the FTC was improperly applying a new standard.
The relevant
factors counseled against the exercise of jurisdiction. First, a ruling wouldn’t finally settle the
controversy between the parties: there would still remain the question of
whether POM’s ads were false, misleading, or unsubstantiated, regardless of the
proper standard. Second, other
proceedings were pending, and the FTC forum was perfectly capable of deciding
statutory and constitutional issues. The
enforcement action might not fully resolve POM’s argument that the FTC had
violated the law by adopting a new standard through consent orders, but POM
would still have a full opportunity to challenge any FTC final action against
it. Third, granting declaratory relief would
require resolving anticipatory defenses, which isn’t ordinarily a proper use of
declaratory judgment. Courts shouldn’t
allow declaratory judgments as a form of forum shopping, and the FTC pointed
out that POM was well aware of the administrative complaint about to be filed
against it. POM apparently sued to get
tactical leverage, even as the enforcement action continues to proceed.
No comments:
Post a Comment